Chargement en cours...
Surrogate markers in antiangiogenesis clinical trials
Novel antiangiogenic agents currently being developed may ultimately be more effective against solid tumours and less toxic than cytotoxic chemotherapy. As a result of the early clinical trials of angiogenesis inhibitors, investigators are beginning to appreciate the complexity of targeting angiogen...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Nature Publishing Group
2003
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2394225/ https://ncbi.nlm.nih.gov/pubmed/12838293 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601035 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|